Medicine
Nitish Kumar, Pedro Lança Gomes, Gaurav A Jategaonkar, Michael J. Marino, A. Miglani, D. Lal
Abstract
We evaluated the impact of teprotumumab therapy (TT) introduction on orbital decompression (OD) utilization for thyroid eye disease (TED) and compared rates of significant exophthalmos reduction (SER) and diplopia between TT and OD.
Citation format
KUMAR, Nitish, et al. Teprotumumab for thyroid eye disease: Efficacy and impact on orbital decompression utilization. Laryngoscope Investigative Otolaryngology, 2026, 11(1): e70351.